Medicare Enrolled

Dr. Kevin Tsai, MD

Interventional Cardiology · Brooklyn, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
121 DEKALB AVE, Brooklyn, NY 11201
7182508265
In practice since 2015 (11 years)
NPI: 1366830689 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tsai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tsai? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tsai

Dr. Kevin Tsai is an interventional cardiology specialist in Brooklyn, NY, with 11 years of NPI registration. Based on federal Medicare data, Dr. Tsai performed 430 Medicare services across 316 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tsai received a total of $10,580 from 34 pharmaceutical and/or device companies across 272 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tsai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ 430 Medicare services $10,580 industry payments

Medicare Practice Summary

Medicare Utilization ↗
430
Medicare services
Bottom 24% in NY for interventional cardiology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
316
Unique beneficiaries
$118
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~39 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
210 $71 $170
Coronary angiography
A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels.
46 $200 $625
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
42 $118 $295
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
40 $114 $320
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
31 $60 $160
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
28 $158 $470
Insertion of implantable heart rhythm monitor
A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit.
17 $82 $230
Coronary stent placement
A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process.
16 $578 $1,580
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.9% high complexity
0.0% medium
89.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,580
Total received (2018-2024)
Avg $1,511/year across 7 years
Top 37% in NY for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
272
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,210 (96.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$370 (3.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,065
2023
$3,029
2022
$2,167
2021
$1,229
2020
$187
2019
$430
2018
$473

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,526
AstraZeneca Pharmaceuticals LP
$314
Boston Scientific Corporation
$199
ShockWave Medical, Inc
$194
Amgen Inc.
$137
Bayer Healthcare Pharmaceuticals Inc.
$134
Abbott Laboratories
$84
Alnylam Pharmaceuticals Inc.
$82
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
CARDIVA MEDICAL, INC.
$60
Avanos Medical
$56
E.R. Squibb & Sons, L.L.C.
$53
Novo Nordisk Inc
$48
Novartis Pharmaceuticals Corporation
$34
Actelion Pharmaceuticals US, Inc.
$30
PFIZER INC.
$19
Merck Sharp & Dohme LLC
$15
Top 3 companies account for 66.6% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$2,140
AstraZeneca Pharmaceuticals LP
$1,755
Janssen Pharmaceuticals, Inc
$862
Boston Scientific Corporation
$811
Abbott Laboratories
$782
Boehringer Ingelheim Pharmaceuticals, Inc.
$490
ShockWave Medical, Inc
$474
Amgen Inc.
$430
CARDIVA MEDICAL, INC.
$272
Esperion Therapeutics, Inc.
$251
ASAHI INTECC USA, INC.
$218
Alnylam Pharmaceuticals Inc.
$193
Bayer Healthcare Pharmaceuticals Inc.
$193
Novartis Pharmaceuticals Corporation
$178
SANOFI-AVENTIS U.S. LLC
$174
ABIOMED
$167
E.R. Squibb & Sons, L.L.C.
$142
Actelion Pharmaceuticals US, Inc.
$135
Astellas Pharma US Inc
$118
Inari Medical, Inc.
$114
PFIZER INC.
$103
Terumo Medical Corporation
$100
Cardiovascular Systems Inc.
$83
Shockwave Medical, Inc
$82
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$79
Avanos Medical
$56
Novo Nordisk Inc
$48
Daiichi Sankyo Inc.
$28
Lantheus Medical Imaging, Inc.
$21
Aurinia Pharma U.S., Inc.
$20
Biosense Webster, Inc.
$17
Chiesi USA, Inc.
$16
Merck Sharp & Dohme LLC
$15
CHIESI USA, INC.
$14
Top 3 companies account for 45.0% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · ASAHI PTCA Guide Wire · AVEIR · BRILINTA · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 5F VCS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CLEVIPREX 50MG/100ML · CardioMEMS HF System · Corlanor · DEFINITY · DIAMONDBACK PERIPHERAL · Diamondback Coronary · Diamondback Peripheral · ELIQUIS · ENTRESTO · EnSite Precision Cardiac Mapping System · Everest Inflation Device · FARXIGA · FFRANGIO · FLOWTRIEVER CATHETER · GENERAL PAIN MANAGEMENT · General - Brady · General - EP · General - Therapies · General - Ultrasound · HEARTRAIL · IN.PACT AV · INJECTAFER · Impella · JARDIANCE · KENGREAL · Kerendia · LEXISCAN · LINQ II · LOKELMA · Launcher · LifeVest · METACROSS OTW · MULTAQ · MYCARELINK · NEXLETOL · NEXLIZET · ONPATTRO · ONYX FRONTIER · OPSUMIT · Ozempic · PNB AND ACCESSORIES · ROTAPRO · Repatha · Resolute · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · UPTRAVI · VERQUVO · Vascular Closure Device · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an interventional cardiology specialist in Brooklyn?
Compare interventional cardiologists in the Brooklyn area by procedure volume, costs, and industry payment transparency.
Browse interventional cardiologists nearby

Geographic Context

Interventional cardiologists within 10 mi
166
Per 100K population
6.3
County median income
$78,548
Nearest hospital
BROOKLYN HOSPITAL CENTER - DOWNTOWN CAMPUS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tsai is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tsai experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Tsai performed 210 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tsai receive payments from pharmaceutical companies?
Yes. Dr. Tsai received a total of $10,580 from 34 companies across 272 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tsai's costs compare to other interventional cardiologists in Brooklyn?
Dr. Tsai's average Medicare payment per service is $118. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tsai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →